-
Myanmar leader lands in Malaysia for migrant return talks
-
Chip industry activists call for South Korea to recognise cancer cases
-
Indian central bank hikes rates for first time since 2023
-
Famine-scarred southern Madagascar braces for El Nino
-
US military on Okinawa face curfew, alcohol ban after murder case
-
How the EU regulates lobbyists
-
Fierce lobbying in EU over 'forever chemicals'
-
I.Coast refuge offers lifelong care for youngsters scorned as 'sorcerers'
-
Dodgers beat Braves and Padres avoid sweep in MLB playoffs
-
Indian central bank hikes rates for first time in more than 3 years
-
Mourning, war and elections as Israel marks October 7
-
Hotel Blacklist Launches New Accommodation Industry Risk Assessment Tool
-
Messi says Argentina retirement is 'saddest day of my career'
-
Bangladesh nuclear plant draws hope -- and worry
-
Oil rises and stocks fall as Hormuz worries flare
-
US beat Canada 1-0 to wrap up four-win international break
-
Pacific presses world for help 'surviving' climate change at pre-COP summit
-
Turkey, Australia's joint COP31 leadership raises doubts
-
Verstappen revival to be put to the test in steamy Singapore
-
For Turkish NGOs, COP31 offers rare space for action
-
US woman who survived botched execution is conscious, speaking: lawyers
-
Sleep, appetite, gene-editing experts contend for Nobel chemistry prize
-
Climate champion Australia digging more coal
-
Nobel Peace Prize haunted by the 'spectre' of Trump
-
Emotion, tears as Messi retires from Argentina national team
-
Africa launches own credit agency in bid for cheaper borrowing
-
Dodgers push Braves to the brink of MLB playoff exit
-
US, China, EU: three paths to regulating AI
-
Crisis-stricken Haiti postpones elections
-
Australia's High Court rules against coal mine in landmark climate case
-
N. Korea's Kim pledges 'invariable support' in Putin birthday letter
-
Australia touts new funds for Pacific infrastructure at Fiji 'pre-COP'
-
OGRD Alliance Advances PLPC Multi-Asset Platform Following APHELAR Milestone, Expanding Licensing and Strategic Capital Frameworks
-
Eva Marie Saint, Oscar winner of Hollywood classics, dies at 102
-
Emotion, tears as Messi prepares for Argentina farewell
-
Australia probes app used in cheap smart glasses over privacy fears
-
Kane eyes Ronaldo record after matching England cap mark
-
England needed to 'move on' from World Cup pain, says Tuchel
-
Spain fight back to beat Croatia, Kane adds to record for England
-
O'Neill to stay at Celtic after period of "reflection"
-
Merino double helps Spain beat Croatia, reach Nations League quarters
-
Kane marks 125th England cap with Wembley Nations League double
-
US stocks hit fresh records as oil stabilizes on rising supplies
-
Quebec's incoming separatist leader wants to block Crown from swearing-in
-
As Messi bows out, Argentines say 'thank you'
-
Emmys gala will now stream its premier television awards
-
Ronaldo opens door for Portugal return, apologises for walkout
-
Paramount completes Warner Bros takeover, creating Skydance
-
'Nobody seems to care': Russian city shrugs off plague reports
-
Trump blames France unrest on Islam, migration
Czechs greenlight magic mushroom use from 2026
The outgoing Czech government said Wednesday it had approved the use of psilocybin -- the active ingredient in magic mushrooms -- for medical purposes from 2026.
Several countries have recently legalised the use by psychiatrists of the naturally occurring hallucinogenic compound, including New Zealand this year.
Lawmakers in the Czech Republic -- an EU and NATO member of 10.9 million people -- legalised the use of psilocybin in May, in an amendment to the penal code which also eased the rules for marijuana possession.
The government decision, which sets the rules for the drug's use, allows psychiatrists and psychotherapists to administer psilocybin if "treatment by registered medical substances is inefficient or if intolerance is proven".
They can only use psilocybin to treat cancer-related depression, clinically serious depression without psychotic symptoms and a worsened mental condition threatening the patient's life.
Health Minister Vlastimil Valek hailed the decision as beneficial for "the Czech health system, the expert public and patients".
In recent years, the therapeutic potential of psychedelic substances like psilocybin, as well as LSD and MDMA, has sparked renewed interest among scientists for treating depression and addiction.
New Zealand approved the use of psilocybin for depression treatment in June.
Germany allowed two clinics to use psilocybin within a "compassionate use programme", the first of its kind in the EU, in July.
Czech doctors have been allowed to prescribe medical cannabis since 2015, and cannabis treatment has been covered by public health insurance since 2020.
The centre-right Czech coalition government of right-winger Petr Fiala held its last meeting on Wednesday.
It will yield to a new coalition cabinet led by billionaire Andrej Babis, which is due to be sworn in next Monday following a general election in October.
L.AbuTayeh--SF-PST